Doctors Lounge: "A new drug based on a compound produced by the human body appears to block fusion peptides and halt an early stage of HIV infection by thwarting interaction between the virus and host cells, according to research published in the Dec. 22 issue of
Science Translational Medicine."
0 comments:
Post a Comment